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2 
ABSTRACT 23 
The genomes of human herpesviruses 6A and 6B (HHV-6A and HHV-6B) have the 24 
capacity to integrate into telomeres, the essential capping structures of chromosomes that play 25 
roles in cancer and ageing. About 1% of people worldwide are carriers of chromosomally 26 
integrated HHV-6 (ciHHV-6), which is inherited as a genetic trait. Understanding the 27 
consequences of integration for the evolution of the viral genome, for the telomere and for the 28 
risk of disease associated with carrier status is hampered by a lack of knowledge about 29 
ciHHV-6 genomes. Here, we report an analysis of 28 ciHHV-6 genomes and show that they 30 
are significantly divergent from the few modern non-integrated HHV-6 strains for which 31 
complete sequences are currently available. In addition ciHHV-6B genomes in Europeans are 32 
more closely related to each other than to ciHHV-6B genomes from China and Pakistan, 33 
suggesting regional variation of the trait. Remarkably, at least one group of European ciHHV-34 
6B carriers has inherited the same ciHHV-6B genome, integrated in the same telomere allele, 35 
from a common ancestor estimated to have existed 24,500 ±10,600 years ago. Despite the 36 
antiquity of some, and possibly most, germline HHV-6 integrations, the majority of ciHHV-37 
6B (95%) and ciHHV-6A (72%) genomes contain a full set of intact viral genes and therefore 38 
appear to have the capacity for viral gene expression and full reactivation. 39 
 40 
IMPORTANCE 41 
Inheritance of HHV-6A or HHV-6B integrated into a telomere occurs at a low frequency in 42 
most populations studied to date but its characteristics are poorly understood. However, 43 
stratification of ciHHV-6 carriers in modern populations due to common ancestry is an 44 
important consideration for genome-wide association studies that aim to identify disease risks 45 
for these people. Here we present full sequence analysis of 28 ciHHV-6 genomes and show 46 
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3 
that ciHHV-6B in many carriers with European ancestry most likely originated from ancient 47 
integration events in a small number of ancestors. We propose that ancient ancestral origins 48 
for ciHHV-6A and ciHHV-6B are also likely in other populations. Moreover, despite their 49 
antiquity, all of the ciHHV-6 genomes appear to retain the capacity to express viral genes, and 50 
most are predicted to be capable of full viral reactivation. These discoveries represent 51 
potentially important considerations in immune-compromised patients, in particular in organ 52 
transplantation and in stem cell therapy.   53 
54 
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INTRODUCTION 55 
Given the complex roles that human telomeres play in cancer initiation and 56 
progression and in ageing (1, 2), it is remarkable that the genomes of human herpesviruses 6A 57 
and 6B (HHV6-A and HHV-6B; species Human betaherpesvirus 6A and Human 58 
betaherpesvirus 6B) can integrate and persist within them (3). Human telomeres comprise 59 
double-stranded DNA primarily composed of variable lengths of (TTAGGG)n repeats and 60 
terminated by a 50-300 nucleotide (nt) 3’ single-strand extension of the G-rich strand. 61 
Telomeres, bound to a six-protein complex called shelterin, cap the ends of chromosomes and 62 
prevent inappropriate double-strand break repair. They also provide a solution to the ‘end 63 
replication problem’ via the enzyme telomerase (4-6). 64 
The double-stranded DNA genomes of HHV-6A and HHV-6B consist of a long 65 
unique region (U; 143-145 kb) encoding many functional open reading frames (ORFs U2-66 
U100), flanked by identical left and right direct repeats (DRL and DRR; 8-10 kb) encoding 67 
two ORFs (DR1 and DR6). Each DR also contains near its ends two variable regions of 68 
telomere-like repeat arrays (T1 and T2) (7, 8), terminated by the viral genome packaging 69 
sequences (PAC1 and PAC2, respectively) (9, 10). Telomeric integration by HHV-6A or 70 
HHV-6B (yielding chromosomally integrated HHV-6, ciHHV-6) results in loss of the 71 
terminal PAC2 sequence at the fusion point between the telomere and DRR-T2 (11) and loss 72 
of the DRL-PAC1 sequence at the other end of the integrated viral genome when the DRL-T1 73 
degenerate telomere-like repeat region becomes part of a newly formed telomere (Figure 1A, 74 
(12)). 75 
Once the HHV-6 genome has integrated in the germline it can be passed from parent 76 
to child, behaving essentially as a Mendelian trait (inherited ciHHV-6) (13-16). The telomere 77 
carrying the ciHHV-6 genome shows instability in somatic cells, which can result in the 78 
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5 
partial or complete release of the viral genome as circular DNA (12, 17, 18). This could 79 
represent the first step towards viral reactivation, and in this respect telomeric integration may 80 
be a form of HHV-6 latency. To date, reactivation of ciHHV-6 has been demonstrated in vivo 81 
in two settings: first, in a child with X-linked severe combined immunodeficiency who was 82 
also a carrier of inherited ciHHV-6A (19); and second, upon transplacental transmission from 83 
two ciHHV-6 carrier mothers to their non-carrier babies (20). Recently, it has been shown that 84 
ciHHV-6 carriers bear an increased risk of angina pectoris (21), although it is not known 85 
whether this arises from viral reactivation, a deleterious effect on the telomere carrying the 86 
viral genome, or some other mechanism. 87 
A small proportion of people worldwide are carriers of inherited ciHHV-6A or -6B, 88 
but very little is known about the HHV-6 genomes that they harbor, although this may 89 
influence any associated disease risk. To investigate ciHHV-6 genomic diversity and 90 
evolution, the frequency of independent germline integrations, and the potential functionality 91 
of the integrated viral genomes, we analysed 28 ciHHV-6 genomes. We discovered that 92 
ciHHV-6 genomes are more similar to one another than to the few sequenced reference HHV-93 
6 genomes from non-integrated viruses. This is particularly marked among the ciHHV-6B 94 
genomes from Europeans. We also found that a subset of ciHHV-6B carriers from England, 95 
Orkney and Sardinia are most likely descendents from a single ancient ancestor. Despite the 96 
apparent antiquity of some, possibly most, ciHHV-6 genomes, we concluded that the majority 97 
contain a full set of intact HHV-6 genes and therefore in principle retain the capacity to 98 
generate viable viruses. 99 
MATERIAL AND METHODS 100 
Population screening to identify ciHHV-6 carriers. ciHHV-6 carriers were identified by 101 
screening a variety of DNA sample collections of individuals from across the world, using 102 
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6 
PCR assays to detect either U11, U18, DR5 (HHV-6A) or DR7 (HHV-6B) (12), or U7, DR1, 103 
DR6A or DR6B ((22) and manuscript in preparation). DR5, DR6A, DR6B and DR7 104 
correspond to ORFs in the original annotation of the HHV-6A genome (GenBank accession 105 
X83413 (23)), but DR5 is in a non-coding region of the genome, and DR6A, DR6B and DR7 106 
are in exons of DR6 in the reannotation used (RefSeq accession NC_001664). From the 107 
populations screened, 58 samples with ciHHV-6 among 3875 individuals were identified 108 
(Table 1). The number of individuals screened in most populations was small and therefore 109 
cannot be used to give an accurate estimate of ciHHV-6A or -B frequencies, although a larger 110 
number of ciHHV-6B-positive samples was identified overall. The frequency of ciHHV-6B 111 
carriers in Orkney (1.9%), a collection of islands off the north coast of Scotland, is higher 112 
than that reported from England (24). Screening of the Generation Scotland: Scottish Family 113 
Health Study (GS:SFHS) will be described elsewhere (RFJ, manuscript in preparation). 114 
Ethical approval for the GS:SFHS cohort was obtained from the Tayside Committee on 115 
Medical Research Ethics (on behalf of the National Health Service). 116 
Generation of overlapping amplicons and sequencing. The 32 primer pairs used to 117 
generate overlapping amplicons from ciHHV-6A genomes, and the PCR conditions 118 
employed, were reported previously (18). The primer pairs used to amplify ciHHV-6B 119 
genomes were based on conserved sequences from the HHV-6B non-integrated HST and Z29 120 
strains (Genbank accessions AB021506.1 and AF157706 respectively; (9, 25). The primer 121 
sequences are shown in Supplementary Table S1. The amplicons from each sample were 122 
pooled in equimolar proportions and then sequenced by using the Illumina MiSeq or 123 
IonTorrent (Life Technologies) next-generation sequencing platforms, as described 124 
previously (18). Some sequences were verified by using Sanger dideoxy chain termination 125 
sequencing on PCR-amplified products. 126 
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7 
Assembly and analysis of DNA sequence data. DNA sequence data were processed 127 
essentially as described previously (18), except that SPAdes v. 3.5.0 (26) was used for de 128 
novo assembly into contigs, ABACAS v. 1.3.1 (27) was used to order contigs, and Gapfiller 129 
v. 1-11 (28) was used to fill gaps between contigs. The integrity of the sequences was verified 130 
by aligning them against the read data using BWA v. 0.6.2-r126
 
and visualizing the 131 
alignments as BAM files using Tablet v. 1.13.08.05. Nucleotide substitutions, indels and 132 
repeat regions were also verified by manual analysis using IGV v. 2.3 133 
(http://software.broadinstitute.org/software/igv/home). 134 
Alignments of the seven ciHHV-6A genomes with the three published HHV-6A 135 
genomes from non-integrated strains U1102, GS and AJ (23, 29-31), and alignment of the 21 136 
ciHHV-6B genomes with the two previously published HHV-6B genomes from non-137 
integrated viruses HST and Z29 (9, 25), were carried out by using Gap4 (32). Variation across 138 
the ciHHV-6 genomes was studied by a combination of manual inspection and automated 139 
analysis by using an in-house Perl script. The script performed a sliding window count of 140 
substitutions using the aligned Gap4 files, reporting the count according to the mid-point of 141 
the window. For analysis across the genome, the window size was 1 kb and the step size was 142 
1 nucleotide. For analysis of individual ORFs, a file with a list of annotated positions was 143 
generated. 144 
Phylogenetic analyses were carried out by using two different methods. Maximum 145 
likelihood trees were built by using the maximum composite likelihood model (MEGA6.0), 146 
and bootstrap values were obtained with 2000 replications. Model selection was carried out 147 
for HHV-6A and HHV-6B separately, and the substitution model with the lowest Bayesian 148 
information criterion was selected (the Tamura 3-parameter model (33) for HHV-6B and the 149 
Hasegawa-Kishino-Yano model for HHV-6A). Median-joining networks were built by using 150 
Network 5.0 (www.fluxus-engineering.com) with default parameters. Sites with missing data 151 
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8 
were excluded from all phylogenetic analyses for both HHV-6A and HHV-6B. The number of 152 
positions analysed for HHV-6B was 130412, and that for HHV-6A was 117900. The time to 153 
the most recent common ancestor (TMRCA) was calculated by using rho as implemented in 154 
Network 5.0. Rho values were transformed into time values by using the accepted mutation 155 
rate for the human genome, 0.5E-09 substitutions per bp per year (34), scaled to the number 156 
of sites analysed. 157 
Comparison of tandem repeat regions. The copy numbers of repeat units in the DR-R, R0, 158 
R1, R2, R3 and R4 tandem repeat regions (9, 25) were determined by manual inspection of 159 
the individual BAM files generated for each sequenced ciHHV-6 genome, with verification 160 
by checking the sequence alignments generated using Gap4. The numbers of copies of 161 
TTAGGG in each DRL-T2 region was determined from PCR amplicons generated using the 162 
DR8F and UDL6R primers (Supplementary Table S1). Each amplicon was purified using a 163 
Zymoclean™ gel DNA recovery kit, and then sequenced by using the Sanger dideoxy chain 164 
termination method. The sequence data were analysed by using the MacVector software. 165 
Variation at the (CA)n repeat array located immediately adjacent to T1 in HHV-6B was 166 
investigated in DRL specifically by reamplification of single telomere length analysis (STELA 167 
(35)) products, using the primers DR1R and TJ1F. The short amplicons were purified and 168 
sequenced as above and compared with the same sequence in the reference HST and Z29 169 
genomes.  170 
Analysis of DRR-T1 region by TVR-PCR 171 
The DRR-T1 regions from ciHHV-6B positive samples were amplified by using the primers 172 
U100Fw2 and DR1R. Telomere variant repeat mapping by PCR (TVR-PCR) was conducted 173 
on each of these amplicons essentially as described before (36, 37) but using an end-labeled 174 
primer, HHV-6B-UDR5F and the unlabeled TAG-TELWRev. The TELWRev primer anneals 175 
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9 
to TTAGGG repeats, allowing amplification of products that differ in length depending on the 176 
location of the TTAGGG repeat with respect to the flanking primer (HHV-6B-UDR5F). The 177 
labeled amplicons from the T1 region were separated by size in a 6% denaturing 178 
polyacrylamide gel.  179 
Analysis of HHV-6 ORFs. The frequency of nucleotide substitutions in each ORF was 180 
determined by a combination of manual inspection and automated analysis using a Perl script, 181 
as described above. The DNA sequences of each of the 86 HHV-6B ORFs from the 21 182 
ciHHV-6B genomes were aligned to identify and compare the number of synonymous and 183 
non-synonymous codon changes within and among genes. In addition the predicted amino 184 
acid sequences for each gene in the 21 ciHHV-6B genomes were aligned to confirm the 185 
number of non-synonymous changes. 186 
Characterisation of chromosome-ciHHV-6 junctions. The junctions between the 187 
chromosome and the ciHHV-6 genome were isolated by PCR amplification using various 188 
primers that anneal to subterminal regions of a variety of human chromosomes in 189 
combination with the DR8F primer. The amplicons were purified as described above and 190 
sequenced by using the Sanger method with a variety of primers (Supplementary Table S1). 191 
The number of repeats present in each junction fragment and the interspersion of TTAGGG 192 
repeats with degenerate repeats was determined by manual inspection using the MacVector 193 
software. 194 
Accession numbers.  195 
The finished sequences have been deposited in GenBank under accession numbers 196 
KY316030-KY316056 (Table 2). The LEI_1501 ciHHV-6A genome reported previously has 197 
the accession number KT355575 (doi:  10.1038/srep22730)(18). 198 
 199 
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10 
RESULTS 200 
Selection of ciHHV-6 carriers and sequence analysis of viral genomes. To investigate 201 
sequence variation among ciHHV-6 genomes, 28 samples were selected for analysis: seven 202 
with ciHHV-6A (including LEI-1501 (18)) and 21 with ciHHV-6B (Table 2). The selected 203 
samples were identified in the various populations screened (Table 1), and included additional 204 
individuals from the London area (16), Scotland and the north of England (22), the Leicester 205 
area of England (18) and the GS:SFHS (RJF, manuscript in preparation). The chromosomal 206 
location of ciHHV-6 genomes, determined by fluorescent in situ hybridisation (FISH), was 207 
available for some samples (16, 18). For other samples the junction between the viral DR8 208 
sequence (a non-coding region near one end of DR) and the chromosome subtelomeric region 209 
was isolated by PCR and sequenced (discussed below). Integration of each ciHHV-6 genome 210 
was confirmed by detection of a telomere at DRL-T1 using STELA (12), or by detection of at 211 
least one copy per cell using droplet digital PCR (22, 38). 212 
Each viral genome from ciHHV-6 carriers was sequenced from pooled PCR 213 
amplicons (12, 18). Full sets of HHV-6 amplicons were readily generated (Fig. 1 and 214 
Supplementary Table S1), demonstrating the robustness of this approach for enriching HHV-215 
6 sequences from ciHHV-6 carriers. The HHV-6 amplicons generated from each carrier had 216 
the expected sizes, with variation only in amplicons encompassing repetitive regions (e.g. the 217 
DRR-T1 region of degenerate telomere-like repeats). This observation indicated that all of the 218 
ciHHV-6 genomes are essentially intact, with the exception of the terminal DRR-PAC2 and 219 
DRL-PAC1 sequences lost during integration (Fig. 1A) (11, 12). 220 
The ciHHV-6 genome sequences were determined by short-read next-generation 221 
sequencing (NGS), with some verification by the Sanger method. De novo assemblies of each 222 
genome were generated with few gaps (Fig. 1). The finished sequences were annotated and 223 
 o
n
 Septem
ber 12, 2017 by SW
ETS SUBSCRIPTIO
N SERVICE
http://jvi.asm.org/
D
ow
nloaded from
 
11 
deposited in GenBank under accession numbers KY316030-KY316056 (Table 2). The 224 
ciHHV-6A genome reported previously by us was included in these analyses (LEI-1501, 225 
KT355575; (18)). 226 
Sequence similarity is greater among ciHHV-6 genomes than to non-integrated HHV-6 227 
genomes. Nucleotide substitution frequencies were analysed across the DR and U regions of 228 
the HHV-6B genome (excluding the tandem repeat regions R-DR, R0, R1, R2, R3 and R4, 229 
see Fig. 1, (9, 25)) for each sequenced ciHHV-6B genome in comparison with the two 230 
available HHV-6B reference genomes from non-integrated strains (HST from Japan, 231 
GenBank accession AB021506, (25) and Z29 from Democratic Republic of Congo 232 
(D.R.Congo), GenBank accession AF157706, (9)). The ciHHV-6B genomes show different 233 
patterns of variation from the reference genomes, with greater divergence from strain Z29 in 234 
the distal portion of the U region (120-150 kb) and across DR (1-8 kb), reaching a maximum 235 
of 35 substitutions per kb in these regions (Fig. 2A). Overall, there is less divergence from 236 
strain HST, although the frequency of substitutions is higher in part of the U region (45-64 237 
kb) compared to strain Z29. To assess sequence variation among the ciHHV-6B genomes, 238 
comparisons were made using the genome in HAPMAP NA10863 (CEPH1375.02) as a 239 
reference. The substitution frequency is considerably less across the viral genomes for 18/20 240 
of the ciHHV-6B genomes from individuals with European ancestry, indicating greater 241 
similarity among them. Notably, the other two ciHHV-6B genomes that showed a higher 242 
substitution frequency in this comparison were in individuals from Pakistan and China, 243 
HGDP00092 and HGDP00813, respectively (Fig. 2A). 244 
Nucleotide substitution frequencies were also analysed across each of the seven 245 
ciHHV-6A genomes in comparison with three non-integrated HHV-6A reference genomes 246 
(strain U1102 from Uganda (39) (accession X83413, (23)); strain GS from the USA 247 
(accessions KC465951.1 (GS1) and KJ123690.1 (GS2) (29, 30)) and strain AJ from the 248 
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12 
Gambia (accession KP257584.1 (31)). This analysis shows that the ciHHV-6A genomes have 249 
similar levels of divergence from each reference genome from non-integrated HHV-6A and 250 
that divergence is highest across DR and the distal part of U (120-149 kb) (Fig. 2B). 251 
Comparisons with the ciHHV-6A LEI-1501 genome (18) as a reference, also showed greater 252 
similarity among the ciHHV-6A genomes although the substitution frequencies are higher 253 
than among European ciHHV-6B genomes, indicating greater diversity among the ciHHV-6A 254 
genomes sequenced here (40). Notably the ciHHV-6A in the Japanese individual (HAPMAP 255 
NA18999) shows greater divergence from the other ciHHV-6A samples of European origin. 256 
 In summary, comparisons of nucleotide substitution frequencies show that the viral 257 
genomes in ciHHV-6B carriers are more similar to each other than they are to reference 258 
genomes derived from clinical isolates of non-integrated HHV-6B from Japan (HST) and 259 
D.R.Congo (Z29). The ciHHV-6A genomes are also more similar to each other than they are 260 
to the three HHV-6A reference genomes, although this is less pronounced than among the 261 
ciHHV-6B genomes.  262 
Phylogenetic analysis of ciHHV-6 and non-integrated HHV-6 genomes. Consistent with 263 
the results shown in Fig. 2, phylogenetic analysis of the U region from 21 ciHHV-6B and the 264 
HST and Z29 reference genomes (excluding DR, the large repeat regions and missing data 265 
shown in Fig. 1) shows that the ciHHV-6B genomes in HGDP00813 from China and 266 
HGDP00092 from Pakistan are outliers to the 19 ciHHV-6B genomes from individuals of 267 
European descent (Fig. 3A). A phylogenetic network of the ciHHV-6B genomes with 268 
European ancestry shows three clusters of 8, 3 and 5 closely related ciHHV-6B genomes 269 
(groups 1, 2 and 3, respectively; Fig. 3B) and three singletons (ORCA1340, COR264 and 1-270 
ciHHV-6B). Phylogenetic analysis of DR alone shows that, with the exception of COR264, 271 
the European ciHHV-6B samples show greater similarity to the HST (Japan) reference 272 
genome than to the Z29 (D.R.Congo) reference genome. However, the DRs in the two non-273 
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13 
European ciHHV-6B samples HGDP000813 (China) and HGDP00092 (Pakistan) do not 274 
cluster closely with those in the European ciHHV-6B samples again indicating these ciHHV-275 
6B strains are distinct (Supplementary Fig. S1 and Fig. 3A).  276 
To explore variation only within HHV-6B genes, the frequency of substitutions in 277 
ORFs of each of the 21 ciHHV-6B genomes was compared with that in the HST and Z29 278 
reference genomes and the ciHHV-6B genome in HAPMAP NA10863 (Fig. 4A). The 279 
patterns of variation were similar to those observed across the whole genome (Fig. 2A) and 280 
consistent with the phylogenetic analysis showing greater similarity among ciHHV-6B in 281 
Europeans and with the subgroups. Phylogenetic analysis of specific genes, which were 282 
selected because they show greater sequence variation from the reference genomes or among 283 
the ciHHV-6B genomes, generated a variety of trees that are generally consistent with the 284 
phylogenetic analysis based on the U region but exhibited less discrimination between 285 
samples or groups (Fig. 4 and Supplementary Fig. S2). For example, the phylogenetic tree 286 
based on U90 separates the European ciHHV-6B samples from the ciHHV-6B samples from 287 
China and Pakistan and from the HST and Z29 reference genomes but does not subdivide the 288 
European ciHHV-6B samples. 289 
Phylogenetic analysis of the seven ciHHV-6A genomes and four reference genomes 290 
(U1102 (Uganda), AJ (Gambia) and two sequences from GS (USA)) shows a clear separation 291 
between the integrated and non-integrated genomes (Fig. 3C and D), with two pairs of closely 292 
related ciHHV-6A genomes (LEI-1501 and GLA_25506; 7A-17p13.3 and GLA_15137). A 293 
similar separation of the integrated versus non-integrated genomes is also evident in the 294 
phylogenetic analysis of DR alone, irrespective of the geographic origin of the individual 295 
ciHHV-6A carrier (Supplementary Fig. S1).  296 
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Variation within HHV-6A genes was also explored by plotting base substitution 297 
frequency per ORF for each of the seven ciHHV-6A samples in comparison to the three 298 
reference genomes and the ciHHV-6A genome in LEI_1501 (Fig. 4B). The patterns of 299 
variation are similar to those observed across the whole genome (Fig. 2B). Phylogenetic 300 
analysis of U83, U90 and DR6, selected because they show greater sequence variation, 301 
generally support the phylogenetic trees and networks generated from analysis of the U and 302 
DR regions (Supplementary Fig. S3). 303 
Overall, the sequence variation and phylogenetic analyses indicate a divergence 304 
between the integrated and non-integrated HHV-6 genomes but with some differences 305 
between the HHV-6A and HHV-6B. The ciHHV-6B samples from individuals with European 306 
ancestry showed divergence from both HST (Japan) and Z29 (D.R.Congo) reference 307 
genomes, although the pattern of divergence varies across the genome. The 21 ciHHV-6B 308 
genomes from individuals with European ancestry are more similar to one another than to the 309 
ciHHV-6B genomes from China and Pakistan and can be subdivided into distinct groups. 310 
There is greater divergence among the seven ciHHV-6A genomes than among the ciHHV-6B 311 
genomes but, despite this, two pairs of closely related ciHHV-6A genomes were identified.  312 
From these analyses, we concluded that the three groups of closely related ciHHV-6B 313 
genomes and the pairs of ciHHV-6A genomes identified in the phylogenetic networks (Fig. 314 
3B and D, respectively) could represent independent integrations by closely related strains of 315 
HHV-6B or HHV-6A. Alternatively, each group might have arisen from a single integration 316 
event, with members sharing a common ancestor. Further analyses were undertaken to 317 
explore these possibilities. 318 
Comparison of tandem repeat regions in ciHHV-6 genomes. Tandem repeat arrays within 319 
the human genome often show length variation as a consequence of changes to the number of 320 
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15 
repeat units present (copy number variation). The greater allelic diversity in these regions 321 
reflects the underlying replication-dependent mutation processes in tandem repeat arrays, 322 
which occur at a higher rate than base substitutions (41). To explore diversity among the 323 
ciHHV-6B genomes further, tandem repeat regions distributed across the viral genome were 324 
investigated. The R-DR, R2A, R2B and R4 repeat regions analysed (location shown in Fig. 325 
1C) showed little or no copy number variation among the ciHHV-6B and non-integrated 326 
reference genomes (Fig. 5A, Table 3). Copy number variation at R1 (location shown in Fig. 327 
1C) was greater but did not show a clear relationship with strains of ciHHV-6B or non-328 
integrated HHV-6B. Greater copy number variation was detected at the pure array of 329 
TTAGGG repeats at DRL-T2 (location shown in Fig. 5B) with the largest number of repeats 330 
in the HHV-6B Z29 reference genome and ciHHV-6B in HGDP00813 from China (Fig. 5A, 331 
Table 3). Notably, copy number variation observed at R0 (location shown in Fig. 1C) 332 
correlates reasonably well with the groups of ciHHV-6B genomes identified the phylogenetic 333 
network (Fig 5A; Table 3; Fig. 3).  334 
Similar analysis of repeat regions in the ciHHV-6A genomes was conducted (Table 3). 335 
The data suggest that ciHHV-6A genomes have fewer TTAGGG repeats at DRL-T2 than in 336 
the HHV-6A reference genomes. This variation could have been present in HHV-6A strains 337 
prior to integration or deletion mutations that reduce the length of the DRL-T2 array may have 338 
been favoured after integration (12). 339 
 To explore variation within the T1 array of degenerate telomere-like repeats in 340 
ciHHV-6B genomes, we amplified the DRR-T1 region by using the U100Fw2 and DR1R 341 
primers, and investigated the interspersion patterns of TTAGGG and degenerate repeats at the 342 
distal end of DRR-T1 (near U100, Fig. 5B) by using modified TVR-PCR (36, 37, 42). 343 
Comparison of the TTAGGG interspersion patterns between the samples showed that the 344 
ciHHV-6B genomes clustered into groups that share similar TVR maps in DRR-T1 (Fig. 5C). 345 
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Furthermore, these interspersion patterns differed between the groups and the singleton 346 
ciHHV-6B genomes identified in the phylogenetic analyses. Variation around the (CA)n 347 
simple tandem repeat, located immediately adjacent to DRL-T1 (location shown in Fig. 5B), 348 
also showed clustering into groups that correlate with the ciHHV-6B phylogenetic analyses 349 
(Fig 5D, Table 3, Fig. 3). Overall, the analyses of tandem repeat regions in the ciHHV-6B 350 
genomes are consistent with the phylogenetic analyses. 351 
Ancestry of ciHHV-6B carriers in group 3. The repeat copy number variation observed 352 
within and among groups may have arisen before or after telomeric integration of the viral 353 
genome. To investigate further how many different integration events may have occurred 354 
among the ciHHV-6B carriers, we isolated and sequenced fragments containing the junction 355 
between the human chromosome and the ciHHV-6B genome, in addition to using the 356 
cytogenetic locations published previously for some samples (Table 2; (16)). The junction 357 
fragments were isolated by a trial-and-error approach, using PCR between a primer mapping 358 
in DR8 in DRR and a variety of primers known to anneal to different subtelomeric sequences 359 
(Fig. 6A), including primers that anneal to the subterminal region of some but not all copies 360 
of chromosome 17p (17p311 (43) and subT17-539 (12)). There was insufficient DNA for 361 
analysis from the sequenced ORCA1340 (singleton) or the ORCA1622 and ORCA3835 362 
(group 3) samples (Fig. 3B). However, analysis of DRR-T1 and the other repeats showed that 363 
the 42 ciHHV-6B carriers from Orkney fall into two groups, that share the same length at 364 
DRR-T1 with either ORCA1340 or with ORCA1622 and ORCA3835 (Table 3). For junction 365 
fragment analysis, we selected ORCA1006 as a substitute for ORCA1340, since it shares the 366 
same DRR-T1 length. Similarly, ORCA1043, ORCA2119 and ORCA1263 were used as 367 
substitutes for ORCA1622 and ORCA3835, since they share a different DRR-TI length. Using 368 
the chromosome 17p primers, junction fragments were generated from all of the group 3 369 
ciHHV-6B samples and from 1-ciHHV-6B (a singleton in the phylogenetic network, Fig. 3). 370 
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Using these primers, PCR products were not amplified from other ciHHV-6B samples in this 371 
study. The sequences of seven junction fragments from group 3 ciHHV-6B genomes 372 
(including NWA008 (44), which is another ciHHV-6B carrier having a viral genome that 373 
belongs to group 3 (data not shown)) were similar to each other but different from the 374 
fragment in sample 1-ciHHV-6B (Fig. 6B). These data indicate the existence of at least two 375 
independent integration events into different alleles of the chromosome 17p telomere, or 376 
possibly into telomeres of different chromosomes that share similar subterminal sequences 377 
(45). 378 
Comparison of the junction fragments from group 3 ciHHV-6B samples shows 379 
remarkably similar TTAGGG and degenerate repeat interspersion patterns (Fig. 6B). The 380 
differences among the interspersion patterns are consistent with small gains or losses that may 381 
have arisen from replication errors in the germline, after integration of the viral genome (36). 382 
Therefore, it is most likely that the ciHHV-6B status of group 3 individuals arose from a 383 
single ancestral integration event. Using the levels of nucleotide substitution between the 384 
group 3 ciHHV-6B genomes, the time to the most recent common ancestor (TMRCA) was 385 
estimated as 24,538 ±10,625 years ago (Table 4). This estimate is based on the assumption 386 
that, once integrated, the ciHHV-6B genome mutates at the same average rate as the human 387 
genome as a whole. However, deviation from this rate would result in an under- or over- 388 
estimation of the TMRCA. 389 
Genetic intactness of ciHHV-6 genomes. The evidence for an ancient origin of some, 390 
probably most, of the ciHHV-6B genomes analysed, and for post-integration mutations in 391 
repeat regions, raised the question of whether these genomes contain an intact set of viral 392 
genes or whether they have been rendered non-functional by mutation. To explore the 393 
consequence of sequence variation among the ciHHV6B genomes, the amino acid sequences 394 
predicted from all genes in the ciHHV-6B genomes were aligned, and the cumulative 395 
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frequencies of independent synonymous and non-synonymous substitutions were determined 396 
(Fig. 7A). The ratio of synonymous:non-synonymous substitutions varies among genes. The 397 
great majority of non-synonymous changes (amounting to 34% of the total) result in single 398 
amino acid substitutions, but one substitution in the U20 stop codon of HGDP00092 is 399 
predicted to extend the coding region by eight codons. Only one substitution, which creates 400 
an in-frame stop codon in U14 of 1-ciHHV-6B, is predicted to terminate a coding region 401 
prematurely. Two of the seven ciHHV-6A genomes also have in-frame stop codons, one in 402 
U79 of GLA_15137 and the other in U83 genes of GLA_4298 (data not shown). 403 
The 21 inherited ciHHV-6B genomes are likely to include mutations that arose before 404 
integration and represent variation among the parental non-integrated HHV-6B strains as well 405 
as mutations that arose after integration. To explore the latter, five group 3 ciHHV-6B 406 
genomes were compared (Fig. 7B). Among the ten substitutions identified, three were in non-407 
coding regions, one was a synonymous mutation in U77, and six were non-synonymous 408 
mutations. From these limited data, it seems likely that the accumulation of mutations after 409 
integration has been random in these ciHHV-6B genomes. 410 
DISCUSSION 411 
In this study, we used comparative analyses to explore diversity among ciHHV-6 412 
genomes in order to understand the factors that influence the population frequencies of 413 
ciHHV-6 and to determine whether the integrated genomes appear to retain the capacity for 414 
full functionality as a virus. We have found that the ciHHV-6B genomes are more similar to 415 
each another than to the two available HHV-6B reference genomes from Japan and 416 
D.R.Congo (Figs 2, 3, 4 ; Supplementary Fig. S1). This is particularly noticeable among the 417 
19 ciHHV-6B genomes from individuals with European ancestry, which are more similar to 418 
each other than they are to the ciHHV-6B genomes in HGDP00092 from Pakistan and 419 
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HGDP00813 from China. This pointer towards a relationship between the integrated HHV-6B 420 
strain and geographical distribution warrants further investigation, if the association between 421 
carrier status and potential disease risk is to be understood fully (21, 46). The smaller group 422 
of seven ciHHV-6A genomes show higher levels of divergence from the three available 423 
HHV-6A reference genomes from the USA, Uganda and the Gambia, and as reported 424 
previously (40). However, in making these observations, the possibility of sample bias should 425 
be considered, both in the geographic distribution of ciHHV-6 genomes analysed and, in 426 
particular, in the small number of non-integrated HHV-6A and HHV-6B genomes that are 427 
available for comparative analysis.  428 
The isolation of chromosome junction fragments from eight ciHHV-6B samples 429 
(seven group 3 samples and 1-ciHHV-6B) by using primers from chromosome 17p 430 
subterminal sequences (43) suggests integration in alleles of the 17p telomere. Given the 431 
variable nature of human subterminal regions (45), the chromosome locations should be 432 
confirmed using a different approach. Nevertheless, comparison of the TTAGGG and 433 
degenerate repeat interspersion patterns at the chromosome-ciHHV-6B junction can be used 434 
to deduce relationships (42, 47) and, combined with the phylogenetic analyses, show that the 435 
individuals carrying a group 3 ciHHV-6B genome share an ancient ancestor. Group 3 includes 436 
individuals from Sardinia, England, Wales and Orkney, with greater divergence between the 437 
ciHHV-6B genomes in the two individuals from Sardinia (HGDP1065 and HGDP1077) than 438 
between the individual from Derby, England (DER512) and the Sardinian (HGDP1065) (Figs. 439 
3, 5, 6 and Tables 2, 3). Moreover there is no evidence of a close family relationship between 440 
the two individuals from Sardinia. Overall, the data are consistent with the group 3 ciHHV-441 
6B carriers being descendants of a common ancestor who existed approximately 24,500 years 442 
ago, similar to the date of the last glacial maximum and probably predating the colonization 443 
of Sardinia and Orkney. 444 
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The population screen of Orkney identified 42 ciHHV-6B carriers (frequency 1.9%, 445 
Table 1) and no ciHHV-6A carriers, which also suggests a founder effect. However, the 446 
Orkney ciHHV-6B samples can be divided into two groups, based on the length of DRR-T1, 447 
the ciHHV-6B phylogenetic analyses and the different integration sites. Therefore, it is likely 448 
that the ciHHV-6B carriers in Orkney are the descendants of two different ciHHV-6B 449 
ancestors, who may have migrated to Orkney independently. This is consistent with the fine 450 
resolution genetic structure of the Orkney population and the history of Orkney, which 451 
includes recent admixture from Norway (Norse-Vikings) (44). 452 
Given the evidence that extant ciHHV-6B carriers in group 3 are descendants of a 453 
single ancient founder with a germline integration, it is plausible that other clusters in the 454 
phylogenetic tree have a similar history. For example the three individuals in group 2 may all 455 
carry a ciHHV-6B integrated in a chromosome 11p telomere. Further verification is required 456 
to support this speculation, and this will be valuable when assessing disease risk associated 457 
with ciHHV-6 integrations in different telomeres.  458 
There is good evidence that ciHHV-6 genomes can reactivate in some settings, for 459 
example when the immune system is compromised (19, 20). However, it is not known what 460 
proportion of ciHHV-6 genomes may retain the capacity to reactivate. We investigated this 461 
question from various angles. We presented evidence that some ciHHV-6 genomes are 462 
ancient and therefore could have accumulated inactivating mutations while in the human 463 
genome. Most of the tandem repeats analysed in ciHHV-6B genomes showed minor 464 
variations in repeat copy numbers (Fig. 5 and Table 3). However, the function of these 465 
regions is unclear, and, as copy number variation exits among the reference genomes, it seems 466 
unlikely that the level of variation detected unduly influences the potential functionality of the 467 
integrated viral genomes. In the protein-coding regions of ciHHV-6B genomes, 34% of 468 
substitutions are non-synonymous and are predicted to cause amino acid substitutions (Fig. 469 
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7). A single potentially inactivating mutation was detected as an in-frame stop codon in gene 470 
U14 in 1-ciHHV-6B. Since this gene encodes a tegument protein that is essential for the 471 
production of viral particles and can induce cell cycle arrest at the G2/M phase (48), it seems 472 
unlikely that this integrated copy of ciHHV-6B would be able to reactivate. However, the 473 
other viral genes may be expressed in this ciHHV-6B genome and the presence of the viral 474 
genome may also affect telomere function. The stop codon in gene U20 in the individual from 475 
Pakistan (HGDP00092) is mutated, and this is predicted to extend the U20 protein by eight 476 
amino acid residues. U20 is part of a cluster of genes (U20-U24) that are specific to HHV-6A, 477 
HHV-6B and their relative human betaherpesvirus 7, and likely plays a role in suppressing an 478 
apoptotic response by the infected host cell (49, 50). Further experimental analysis will be 479 
required to determine whether the modest extension affects the function of the U20 protein. 480 
Among the seven ciHHV-6A genomes, two contain novel in-frame stop codons. One of these 481 
is located in U83 in GLA_4298. The other is present in U79 in GLA_15137, but this 482 
inactivating mutation is absent from the closely related ciHHV-6A genome in 7A-17p13.3 483 
(Fig. 3C and D). 484 
In summary, we have shown that most ciHHV-6A and ciHHV-6B genomes contain an 485 
intact set of genes and therefore may have the potential to be fully functional. This 486 
observation needs to be taken into consideration when assessing whether ciHHV-6 carrier 487 
status is associated with disease risk and in understanding the underlying mechanisms of such 488 
associations (e.g. whether viral reactivation is involved). Among the individuals of European 489 
descent, we found strong evidence for the ancient common ancestry of some of the integrated 490 
viral genomes. The close similarity between ciHHV-6B genomes in the Europeans and the 491 
evidence of multiple different integration events by similar strains also indicate that we have 492 
effectively sequenced the ancient, non-integrated strains of HHV-6B that existed in European 493 
populations in prehistoric times. Based on these observations, it is possible that other 494 
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populations, for example in China, South Asia and Africa, may show similar founder effects 495 
among ciHHV-6 carriers but from different ancient strains (51). Our limited knowledge of 496 
non-integrated HHV-6A and HHV-6B strains is based mostly on strains derived from Africa 497 
and Japan. There is now a real need to sequence non-integrated strains from other 498 
populations, including those in Europe, so that the relationship between non-integrated HHV-499 
6 and ciHHV-6 can be fully understood. A major challenge will be to determine whether 500 
germline integration continues to occur de novo today, and, if so, at what rate and by which 501 
viral strains. 502 
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Table 1. Summary of populations screened for ciHHV-6 670 
 Region Samples Total 
ciHHV-6 
ciHHV-6A ciHHV-6B 
Africa Sub-Saharan Africa 105 0 0 0 
North Africa 29 0 0 0 
Europe North European 
Extraction (CEPH) 
136 2 0 2 
British 518 7 1 6 
Orkney 2194 42 
(1.9%) 
0 42 
Italy (including 
Sardinia) 
49 2 0 2 
France 52 0 0 0 
Russia 42 0 0 0 
Middle East Israel 134 2 2 0 
South/Central 
Asia 
Pakistan 192 1 0 1 
Uygur (China) 10 0 0 0 
East Asia China 213 1 0 1 
Japan 74 1 1 0 
Others (Siberia & 
Cambodia) 
35 0 0 0 
Oceania Bougainville 17 0 0 0 
 New Guinea 11 0 0 0 
America South America 29 0 0 0 
Mexico 35 0 0 0 
TOTAL 3875 58 4 54 
a 
In addition AJB, RFJ and colleagues have screened the Generation Scotland: Scottish Family Health 671 
Study cohort for ciHHV-6 (manuscript in preparation). 672 
 673 
  674 
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Table 2. Samples from individuals with ciHHV-6 selected for viral genome sequencing. 675 
Sample Acc. No ciHHV-6  Integration Site a Population or Country 
LEI-1501 b KT355575 A 19q Leicester area (England) 
HAPMAP NA18999 KY316047 A - Japan 
3A-10q26.3 c KY316049 A 
10q26.3 & junction 
isolated by PCR 
South-East England 
GLA_4298 d KY316056 A - Newcastle (England) 
GLA_15137 e KY316055 A - Scotland 
GLA_ 25506 e KY316054 A - Scotland 
7A-17p13.3 c KY316048 A 17p13.3 South-East England 
HGDP00092 KY316037 B - Balochi (Pakistan) 
HGDP00813 KY316036 B - Han (China) 
HGDP01065 KY316035 B 
Junction isolated by 
PCR 
Sardinia (Italy) 
HGDP01077 
KY316034 
B 
Junction isolated by 
PCR 
Sardinia (Italy) 
HAPMAP NA07022 
(CEPH 1340.11) 
KY316039 B - 
Utah Mormon  
(North European) 
HAPMAP NA10863 
(CEPH-1375.02) 
KY316038 B - 
Utah Mormon  
(North European) 
4B-11p15.5 c KY316044 B 11p15.5 Southern East England 
BAN519 f KY316043 B - Banff (Scotland) 
COR264 f KY316042 B - Cornwall (England) 
CUM082 f KY316041 B - Cumbria (England) 
DER512 f KY316040 B 
Junction isolated by 
PCR 
Derbyshire (England) 
2B-9q34.3 c KY316045 B 9q34.3 South-East England 
1-ciHHV-6B c KY316046 B 
Junction isolated by 
PCR 
South-East England 
LEI-ALD KY316033 B - Leicester area (England) 
ORCA1622  KY316031 B - Orkney 
ORCA1340  KY316032 B - Orkney 
ORCA3835  KY316030 B - Orkney 
GLA_3986 d KY316053 B - Newcastle (England) 
GLA_29221 e KY316052 B - Scotland 
GLA_34108 e  KY316051 B - Scotland 
GLA_35629 e KY316050 B - Scotland 
a Determined by FISH or amplification of chromosme-ciHHV-6 junctions by PCR; b LEI-1501 described in (18); 
c ciHHV-6 carriers describe in (16); d ciHHV-6 carriers previously described in (22); e ciHHV-6 carriers 
identified in the GS: SFHS; f Samples from the Population of British Isles study (44). 
676 
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Table 3. Variation in tandem repeat regions among ciHHV-6. 677 
Tandem repeat regions in HHV-6B 
Name T1  STR (CA)n  R-DR 
a  
T2  R0 a  R1  R2A 
a  
R2B  R3  R4 a  
Location    adjacent to 
DR-T1 
DR  DR  U1  U86  U86-
U89  
U86- 
U89 
U91-
U94  
After 
U100  
Length (bp) 6 2 15 6 ~15  12 79 12 - 
15 
~104 64 
Unit   CA NI b  (TTAGGG) NI  NI  NI  NI  NI  NI  
HST 
c
 -  12 6 26 17 51 4 6 -  6 
Z29 
c
 -  1 4 77 13 53 4 8 -  4 
HAPMAP 
NA10863 
-  20 5 28 16 44 4 7 -  4 
2B-9q34.3 -  20 5 26 19 44 4 7 -  4 
CUM082 -  19 5 27 19 45 4 7 -  4 
BAN519 -  19 5 28 16 44 4 7 -  4 
GLA_3986  -  20 5 -  19 44 4 7 -  2 
GLA_29221  -  19 5 -  19 45 4 7 -  4 
GLA_34108  -  19 5 -  19 43 4 7 -  4 
GLA_35629  -  - 5 -  19 45 4 7 -  4 
HAPMAP 
NA07022 
-  11 5 29 10 46 4 6 -  4 
4B-11p15.5 -  11 5 26 10 47 4 6 -  4 
LEI-ALD -  11 5 25 10 47 4 6 -  4 
HGDP01065 -  10 5 15 16 44 4 7 -  4 
HGDP01077 -  10 5 19 16 43 4 7 -  4 
DER512 -  10 5 21 16 43 4 7 -  4 
ORCA1622 -  - 5 -  16 43 4 7 -  3 
ORCA3835 -  - 5 -  16 43 4 7 -  3 
ORCA1340 -  - -  -  16 48 4 6 -  4 
1-ciHHV-6B -  12 5 16 16 43 4 6 -  4 
COR264 -  12 9 28 19 44 4 7 -  2 
HGDP00813 -  20 3 53 12 52 4 7 -  4 
HGDP00092 -  1 2 19 17 55 4 11 -  3 
Tandem repeat regions in HHV-6A         
  T1  T2  R5 d  R1  R2  R3      
Location    DR U41 -
U42  
U86  U86 
-U89  
 U91 
-U94      
Length (bp) 6 6 ~191  ~12  12-
18 
104-
105     
    (TTAGGG) NI NI NI NI     
AJ 
c
 -  51 1.7 52 43 8     
U1102 
c
  -  59 1.7 52 102 29     
GS1/2 
c
 -  51 1.7 52 78 8     
LEI-1501 -  14 2.7 -  -  -      
GLA_25506 -  -  2.7 32 -  -      
GLA_4298 -  -  3.7 53 -  -      
HAPMAP 
NA18999 
-  13 1.7 -  -  -  
    
3A-10q26.3 - 9 1.7 58 -  -      
GLA_15137 -  -  1.7 55 -  -      
7A-17p13.3 -  -  1.7 55 -  -      
a
 Repeats specific to HHV-6B - the coordinates of R-DR and R4 in HHV-6B strain HST are 5400-5489 and 
152603-152986 respectively; b NI, repeats not identical; c Reference genomes in bold; d Repeat specific to HHV-
6A - the coordinates of R5 in HHV-6A strain U1102 are 68124-68450; the other repeats are described in (9) 
(25); hyphens, analysis not completed. The samples in the same box are in the same group in the phylogenetic 
networks. 
678 
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Table 4. Estimate of TMRCA for ciHHV-6B genomes in group 3. 679 
 Entire group 3 a HGDP1065 & 
HGDP1077 
HGDP1065 & 
DER512 
TMRCA (y) 24,538 23,004 15,336 
Standard deviation 10,625 13,281 10,844 
 
a ORCA1622 and ORCA3835 are identical across non-repeat regions. 
 
 680 
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Figure Captions 682 
Figure 1.  Approach to sequencing ciHHV-6 genomes. (A) Diagram showing the 683 
organisation of the HHV-6 genome following integration of a single full-length copy into a 684 
telomere. Chromosome and centromere (Cen) are shown by blue lines and an oval. The 685 
telomere repeats are shown by red arrows. The telomere, encompassing DRL-T1, is shown by 686 
a red dashed line. The junction between the chromosome and HHV-6 genome, encompassing 687 
telomere repeats and DRR-T2, is shown by a dashed blue line. DRL and DRR are shown as 688 
blue boxes. (B) Distribution of numbered PCR amplicons across the HHV-6B genome and an 689 
example gel of PCR products generated from 1-ciHHV-6B. (C) Sequence coverage for 690 
individual ciHHV-6B genomes. Each ciHHV-6B genome is shown with a single DR (blue 691 
box) that was covered by amplicons from DRL and DRR and with U (grey box). Gaps in the 692 
coverage caused by loss of individual amplicons at the amplicon-pooling stage are shown in 693 
white. Tandem repeat regions that were fully sequenced by either Illumina NGS or by the 694 
Sanger method are shown in orange. Tandem repeat regions (e.g. T1 and R3 in HHV-6B) that 695 
were too long to be sequenced fully are shown as hashed-brown boxes. (D) Distribution of 696 
numbered PCR amplicons across the HHV-6A genome and an example gel of products 697 
generated from HAPMAP NA18999. (E). Sequence coverage for each ciHHV-6A genomes, 698 
using the same colour coding as in (C). 699 
 700 
Figure 2.  Frequency of nucleotide substitutions in ciHHV-6 genomes compared to reference 701 
viral genomes. (A) Graphs showing the number of substitutions in 1 kb windows for each of 702 
the 21 ciHHV-6B genomes in comparison with the HHV-6B strain HST (Japan) and Z29 703 
(D.R.Congo) genomes (top and middle panels, respectively) and the ciHHV-6B genome from 704 
HAPMAP NA10863 (bottom panel). The colour-coded key shows that ciHHV-6B genomes 705 
from individuals with European ancestry are represented as light blue lines; ciHHV-6B in 706 
HGDP00813 (China), red lines; ciHHV-6B in HGDP00092 (Pakistan), black lines. (B) 707 
Graphs showing the number of substitutions in 1 kb windows for each of the 7 ciHHV-6A 708 
genomes in comparison with the HHV-6A strain U1102 (Uganda), GS (USA) and AJ 709 
(Gambia) genomes (top and two middle panels) and the ciHHV-6A genome in LEI-1501 710 
(bottom panel). The colour-coded key distinguishes the ciHHV-6A genomes. The x-axes in 711 
all the graphs show the HHV-6B and -6A genomes with a single DR (0-8kb) followed by  U 712 
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(9-150kb) as shown in Figure 1C and 1E. Variation within the tandem repeat regions is not 713 
shown in these graphs.  714 
 715 
Figure 3. Phylogenetic analysis of ciHHV-6 and reference non-integrated HHV-6 genomes. 716 
(A) Maximum likelihood phylogenetic tree of 21 ciHHV-6B genomes and two HHV-6B 717 
reference genomes (strains HST (Japan) and Z29 (D.R Congo)). A total of 130412 718 
nucleotides were analysed, excluding repeat regions and missing amplicons. The scale bar 719 
represents 0.0005 substitutions per site. (B) Phylogenetic network generated from the dataset 720 
used in (A), but without the HST and Z29 genomes and the ciHHV-6B genomes from 721 
HGDP00813 (China) and HGDP00092 (Pakistan). The ciHHV-6B genomes from Europeans 722 
in groups 1, 2 and 3 are shown as blue, orange and green dots, respectively and the singletons 723 
are shown as grey dots. (C) Maximum likelihood phylogenetic tree of seven ciHHV-6A 724 
genomes and four HHV-6A reference genomes (strains U1102 (Uganda), AJ (Gambia), GS1 725 
(USA) and GS2 (USA); GS1 and GS2 are two versions of strain GS). A total of 117900 726 
nucleotides were analysed, excluding repeat regions and missing amplicons. The scale bar 727 
represents 0.002 substitutions per site. (D) Phylogenetic network generated from the dataset 728 
used in (C). The non-integrated HHV-6A reference genomes are shown as yellow dots. The 729 
closely related ciHHV-6A genomes are shown as pairs of red or blue dots and singletons as 730 
grey dots (including one from Japan). The scale bars in the networks (C and D) show the 731 
number of base substitutions for a given line length. The dots are scaled, the smallest dot 732 
representing a single individual.    733 
 734 
Figure 4. Frequency of nucleotide substitutions in ciHHV-6 genes compared to those in 735 
reference viral genomes. (A) Graphs of substitution frequency in each gene are shown for the 736 
21 ciHHV-6B genomes in comparison with HHV-6B strains HST (Japan) and Z29 737 
(D.R.Congo) genomes (top and middle panels, respectively) and the ciHHV-6B genome in 738 
European HAPMAP NA10863 (bottom panel). The colour coding shown in the key matches 739 
that of the network in Figure 3B as follows: European Group 1, pale blue lines; European 740 
Group 2, orange lines; European Group 3, green lines; European singletons, grey lines; 741 
ciHHV-6B in HGDP00813 from China, red lines; and ciHHV-6B in HGDP00092 from 742 
Pakistan, black lines. (B) Graphs of substitution frequency in each gene for each of the 7 743 
ciHHV-6A genomes in comparison with the HHV-6A strains U1102 (Uganda), GS (USA) 744 
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and AJ (Gambia) genomes (top and two middle panels) and the ciHHV-6A genome in 745 
European LEI-1501 (bottom panel). The colour-coded key matches that of the network in 746 
Figure 3D. The x-axes of all the graphs show a single copy of DR1 and DR6, followed by 747 
genes found in the U region.   748 
 749 
Figure 5. Copy number variation in tandem repeat loci across the HHV-6B genome. (A) 750 
Graph of the number of repeat units at loci within the DR (R-DR and DRL-T2) and U regions 751 
(R0, R1, R2A, R2B and R4). Comparisons can be made among the reference non-integrated 752 
HHV-6B strains, HST (Japan) and Z29 (D.R. Congo) and ciHHV-6B genomes. The sample 753 
order along the x-axis as follows: HST, Z29 (mauve highlight); European group 1 ciHHV-6B 754 
genomes (blue highlight); European group 2 ciHHV-6B genomes (orange highlight); 755 
European group 3 ciHHV-6B genomes (green highlight); European singleton ciHHV-6B 756 
genomes (no highlight); ciHHV-6B in HGDP00813 from China (red highlight); and ciHHV-757 
6B in HGDP00092 from Pakistan (no highlight). (B) Diagram showing the location of the 758 
PCR amplicons used to analyse the repeat sequences shown in C and D. Black dashed line 759 
shows the amplicon generated by the U100Fw2 and DR1R primers that were used for TVR-760 
PCR shown in (C). Red dashed line shows STELA products, generated from DR1R, that were 761 
used to analysis the (CA)n repeat shown in D. (C) Distribution of (TTAGGG) repeats at the 762 
distal end of DRR-T1 (near U100) in ciHHV-6B genomes. If the repeat array comprises 763 
consecutive TTAGGG repeats, a ladder of bands with 6 base periodicity should be present 764 
and the migration distance between the rungs on the ladder should steadily decrease as the 765 
separation between the bands is reduced (near the top of the gel, towards DR1). The observed 766 
distance between the bands in each track varies between the samples. This shows that the 767 
repeat array is not pure (TTAGGG)n but includes intervening sequence, most likely 768 
degenerate telomere-like repeats. The pattern of repeats can be compared between the tracks 769 
to identify samples that share the same repeat distribution at this end of the DRR-T1. The 770 
ciHHV-6B sample names are colour-coded in accordance with groupings identified in Figure 771 
3: European group 1, blue; group 2, orange; group 3, green; European singletons, grey; 772 
ciHHV-6B in HGDP00813 from China, red; ciHHV-6B in HGDP00092 from Pakistan, black.  773 
(D) Variation in copy number of (CA) repeats and adjacent 5’- sequence, near the start of the 774 
ciHHV-6B DRL-T1 region. Sample names colour-coded as described in (C). 775 
 776 
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Figure 6. Characterisation of ciHHV-6B integration sites.  (A) Diagram showing the location 777 
of PCR amplicons used to characterise the chromosome-ciHHV-6B junctions. Red arrows 778 
represent TTAGGG and degenerate repeats. Blue arrows, primers used to amplify the 779 
chromosome-HHV-6 junction; blue dashed line, chromosome-junction amplicon used for 780 
sequence analysis. (B) Diagram showing the similarity of the TTAGGG (red squares) and 781 
degenerate repeat (coloured squares in key to right) interspersion patterns in the chromosome-782 
HHV-6 junctions from individuals with group 3 ciHHV-6B genomes (DER512 to 783 
HGDP01065, Figure 3B). These interspersion patterns are distinct from that of the 784 
chromosome-junction fragment isolate from 1-ciHHV-6B (singleton in Figure 3B). The 785 
sequence to the left of the repeats is from the chromosome subtelomeric region and the 786 
sequence to the right is from the ciHHV-6B genome.  787 
 788 
 789 
Figure 7. Consequences of nucleotide substitutions across the ciHHV-6 genome.  (A) 790 
Comparison of synonymous (blue) and non-synonymous (orange) substitution frequencies in 791 
each ciHHV-6B gene among the 21 ciHHV-6B genomes (scaled to differences per 1000 792 
amino acids). The green dot shows the novel in-frame stop codon in U14 of 1-ciHHV-6B. 793 
The pie chart shows the overall proportions of synonymous and non-synonymous 794 
substitutions across all genes. (B) Diagram showing the approximate location and 795 
consequence of nucleotide substitutions that are predicted to have arisen after integration in 796 
group 3 ciHHV-6B genomes. The horizontal line represents the HHV-6B genome; black dots, 797 
location of non-coding base substitutions; red dots, base substitutions within HHV-6B genes 798 
that are predicted to result in an amino acid substitutions (non-synonymous) shown by the 799 
text; pink dot, synonymous  (T to C) substitution in DER512 that is not predicted to change 800 
the phenylalanine. HGDP01065, green text; HGDP01077, orange text; DER512 in blue and 801 
the identical sequences found in ORCA1622 and ORCA3835 in purple. The number of 802 
repeats in three regions (T2, R1 and R4) that vary among the group 3 genomes are also 803 
shown.  804 
 805 
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